Fixed Dose combination (FDC) [Design Issues]

posted by drplacebo – 2007-06-27 08:04 (6942 d 20:47 ago) – Posting: # 836
Views: 4,629

Dear HS
We are planning for a dossier submission of a FDC to europe. It has three strengths - 80+12.5, 160+12.5 & 160+25. In this If I plan a study on 160+25, can I get a waiver for the other two strengths.
All these strengths have qualitatively same composition and dose-weight proportionate, except the 160+12.5, where it is not. Should I do an additional study on this strength?

Complete thread:

UA Flag
Activity
 Admin contact
23,656 posts in 4,994 threads, 1,570 registered users;
175 visitors (0 registered, 175 guests [including 39 identified bots]).
Forum time: 04:51 CEST (Europe/Vienna)

It requires a very unusual mind
to undertake the analysis of the obvious.    Alfred North Whitehead

The Bioequivalence and Bioavailability Forum is hosted by
BEBAC Ing. Helmut Schütz
HTML5